Management of Lost Atherectomy Devices in the Coronary Arteries

Gregor Leibundgut1, Alexandru Achim2, Daniel Weilenmann3

  • 1Department of Cardiology, University Hospital Basel, Basel, Switzerland.

Insights

Lost atherectomy devices are a rare but serious complication during coronary procedures. This review updates management strategies, including a novel conservative approach for lost rotational or orbital atherectomy devices.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Devices
  • Medical Complications

Background:

  • Rotational atherectomy and orbital atherectomy are key treatments for calcific coronary disease.
  • Device entrapment and subsequent loss are serious complications during these procedures.
  • Increased adoption of atherectomy necessitates understanding and managing these rare events.

Purpose of the Study:

  • To review contemporary management strategies for lost atherectomy devices in coronary arteries.
  • To present a unique cohort of patients with retained atherectomy devices.
  • To propose an updated algorithmic approach to managing lost atherectomy devices.

Main Methods:

  • Review of literature and case series on lost atherectomy devices.
  • Analysis of management techniques for device entrapment and loss.
  • Development of a management algorithm incorporating conservative strategies.

Main Results:

  • Current recommendations for entrapment typically involve device removal via percutaneous or surgical methods.
  • Conservative management of retained devices has not been traditionally recommended.
  • The study introduces a contemporary algorithmic approach, including a conservative arm.

Conclusions:

  • Management of lost atherectomy devices lacks a clear consensus due to limited reported cases.
  • An updated algorithmic approach, considering a conservative strategy, is proposed.
  • This review aims to guide interventional cardiologists in managing this challenging complication.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
38
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
32
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
28
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
59